Comparison Chart Amarin Corporation plc

Stocks

AMRN

US0231114044

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 17:26:22 28/10/2026 +03			5-day change	1st Jan Change
12.70 ^USD	+6.23%		+9.82%	-9.42%

10-25	Amarin Corporation plc Provides Update on University of Leeds Sponsored Phase 3 Epa for Metastasis Trial 2 Evaluating Vazkepa/Vascepa Capsules in Patients Undergoing Liver Resection for Colorectal Cancer Liver Metastases	CI
10-19	European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	AMARIN CORPORATION PLC	Bio Therapeutic Drugs	+5.77%	+9.82%	-9.42%	-33.26%	-86.47%	252M